SCHEMBL7447294

SCHEMBL7447294

COC(=O)c1c(O)nc(C)c2cc(OC)c(OC)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.42
GABRA1 P14867 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
GABRA2 P47869 1/20 0.41
GABRA6 Q16445 1/20 0.41
CYP3A4 P08684 2/20 0.41
HPGD P15428 1/20 0.41
PDE3B Q13370 3/20 0.40
PDE3A Q14432 3/20 0.40
PDE1A P54750 2/20 0.40
PDE1B Q01064 2/20 0.40
PDE1C Q14123 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
RAC1 P63000 2/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12325390 0.86 CYP3A4 (0.46) KDM4ECYP3A4PDE3BPDE3AMEN1
Hydrochloric Acid SCHEMBL27947697 0.86 KDM4E (0.46) KDM4ECYP3A4HPGDPDE3BPDE3A
SCHEMBL7426747 0.79 ALDH1A1 (0.42) KDM4EGABRA1GABRA5GABRA3GABRA2
SCHEMBL6313239 0.76 KDM4E (0.49) KDM4EHPGDPDE3BPDE3AL3MBTL1
SCHEMBL7445322 0.76 ALDH1A1 (0.47) KDM4EL3MBTL1MEN1KMT2ARAC1
Water SCHEMBL9830187 0.75 ALDH1A1 (0.46) KDM4EL3MBTL1MEN1KMT2ARAC1
Water SCHEMBL9830179 0.75 ALDH1A1 (0.46) KDM4EL3MBTL1MEN1KMT2ARAC1
SCHEMBL7309250 0.75 PDE3B (0.44) KDM4EGABRA1GABRA5GABRA3GABRA2
SCHEMBL9831668 0.75 KMT2A (0.40) KDM4EHPGDMEN1KMT2ARAC1
SCHEMBL7305960 0.74 KDM4E (0.38) KDM4EGABRA1GABRA5GABRA3GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4880817-A O-functionalized derivatives of substituted isoquinolin-3-ols having cardiotonic and/or phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-11-14 US disclosed